Implicit provider bias in cancer clinical trial enrollment: A scoping review
Preprint
Abstract
Background: The lack of racial and ethnic representation in cancer clinical trials further exacerbates existing health disparities and has been linked to inequitable and unequal distribution of resources, social determinants of health, racism, and most recently, provider implicit bias. The purpose of this scoping review is to describe the evidence of implicit bias as it relates to cancer clinical trial enrollment. Methods: Systematic methods were followed to search online databases for publications that assessed provider bias and cancer clinical trial offers through August 1, 2023. Variables of interest included how implicit bias was defined or measured, what type of bias was examined, and if provider implicit bias was identified or described in the cancer clinical trial enrollment process. Results: We identified 10 publications that met the inclusion criteria. Nine of ten studies were conducted in the United States, and all studies utilized observational or qualitative study design. Most assessed the provider perspective, and one study used a validated measure to identify implicit bias. Some studies identified evidence of implicit provider bias in clinical trial discussions and offers; however, it was observed in situations where system constraints, such as lack of resources or time were present that may be common in oncological settings. Conclusions: Multilevel support and dedication to improving racial, ethnic, and other patient-level representativeness are required to mitigate the influence of implicit bias in resource-poor and stressful clinical settings to ensure equitable access to and enrollment in clinical trials for all patients with cancer. Registration: The protocol for this scoping review was registered to Open Science Framework (1), https://osf.io/a6kbt/?view_only=0a857280364a49b9b3f8363b91b00994 .Keywords
This publication has 38 references indexed in Scilit:
- Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providersCancer, 2020
- Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trialsCancer, 2020
- Insomnia Pharmacotherapies: Pharmacodynamics, Strategies, New Directions, and Key Measures in Clinical Trials2019
- Ageism among physicians, nurses, and social workers: findings from a qualitative studyEuropean Journal of Ageing, 2016
- Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?Cancer, 2013
- Physicians and Implicit Bias: How Doctors May Unwittingly Perpetuate Health Care DisparitiesJournal of General Internal Medicine, 2013
- Pediatric oncologists' attitudes towards involving adolescents in decision‐making concerning research participationPediatric Blood & Cancer, 2010
- Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic reviewCancer, 2007
- Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollmentCancer Detection Prevention, 2006
- Factors that influence Spanish‐ and English‐speaking participants' decision to enroll in cancer randomized clinical trialsPsycho-Oncology, 2005